Myrtle S Potter is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 10,822 shares of DNA, which is worth approximately $99,237. The most recent transaction as insider was on Jun 11, 2025, when has been sold 10,822 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.8K
n/a 3M change
n/a 12M change
Total Value Held $99,237

MYRTLE S POTTER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2025
BUY
Exercise of conversion of derivative security
-
10,822 Added 50.0%
10,822 Class A Common Stock

Also insider at

RAD
RITE AID CORP Healthcare
UROV
Urovant Sciences Ltd.
MYOV
Myovant Sciences Ltd. Healthcare
GH
Guardant Health, Inc. Healthcare
MSP

Myrtle S Potter

Director
Camp Hill, PA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA